100 units/ml solution for injection in cartridge insulin aspart
What NovoRapid Penfill is and what it is used for
NovoRapid is modern insulin (insulin analog) that is fast-acting. Modern insulins are improved versions of human insulin.
NovoRapid is used for lowering high blood sugar in adults, adolescents, and children 1 year of age or older with diabetes ( diabetes mellitus ). Diabetes is a disease in which your body does not produce enough insulin to keep your blood sugar levels under control. Treatment with NovoRapid helps prevent complications of your diabetes.
NovoRapid starts lowering your blood sugar 10-20 minutes after you inject it. The effect is strongest 1-3 hours after injection and lasts for 3-5 hours. Due to the short duration of action, NovoRapid should normally be taken in combination with medium- or long-acting insulin preparations.
What you need to know before using NovoRapid Penfill
Do not use NovoRapid
- if you are allergic to insulin aspart or any of the other ingredients of this medicine (listed in section 6, Contents of the pack and other information).
- if you feel you are experiencing insulin sensation (symptoms of low blood sugar) (see a) Summary of serious and very common side effects in section 4).
- if cartridge one or the injection device containing cartridge one has been dropped, damaged or shocked.
- if your insulin has not been stored properly or frozen (see section 5, How to store NovoRapid).
- if the insulin solution is not clear and colorless.
If any of these apply to you, do not use NovoRapid. Talk to a doctor, nurse, or pharmacist.
Before using NovoRapid
- Check on the label that it is the right kind of insulin .
- Always check the cartridge one, including the rubber plunger at the bottom of the cartridge one. Do not use it if it has any visible damage or if the rubber plunger has been pulled over the white line on the label at the bottom of the cartridge . In that case, return it to the pharmacy. See further in the operating instructions.
- Always use a new injection needle for each injection to prevent contamination.
- Injection needles and NovoRapid Penfill must not be shared with anyone else.
- NovoRapid Penfill should only be injected under the skin with a reusable pen. Talk to your doctor if you need to inject your insulin using another method.
Warnings and cautions
Certain conditions and activities may affect your need for insulin. Consult a doctor:
- if you have problems with your kidneys, liver, adrenal glands, pituitary gland or thyroid gland.
- if you exercise more than usual or want to change your diet, as this can affect your blood sugar level.
- if you become ill: continue to take your insulin and consult a doctor.
- if you are traveling abroad: travel over different time zones can affect your insulin needs and when to inject .
Skin changes at the injection site
To help prevent changes in the adipose tissue under the skin, e.g. skin thickening, skin shrinkage, or lumps under the skin, you should always change the injection site. Insulin may not work as well if you inject in an area with lumps or in a thickened or shrunken area (see “How to use NovoRapid”). Contact your doctor if you notice skin changes at the injection site and before changing the injection site if you are currently injecting in an affected area. Your doctor may advise you to check your blood sugar more often and to adjust your insulin dose or the dose of other diabetes medicines.
Children and young people
Do not give this medicine to children under 1 year of age as no clinical studies have been performed in children under 1 year of age.
Other medicines and NovoRapid Penfill
Tell your doctor, nurse, or pharmacist if you are taking or have recently taken or might take any other medicines.
Some medicines affect your blood sugar level, which may mean that your insulin dose needs to be changed. Below is a list of the most common medicines that may affect your insulin treatment.
Your blood sugar level may drop (hypoglycemia) if you take:
- Other medicines to treat diabetes
- MAO inhibitors (for the treatment of depression)
- Beta-blockers (for the treatment of high blood pressure )
- ACE inhibitors (for the treatment of certain heart diseases or high blood pressure )
- Salicylates (analgesics and antipyretics)
- Anabolic steroids (eg testosterone )
- Sulfonamides (for the treatment of infections ).
Your blood sugar level may rise (hyperglycemia) if you take:
- Oral contraceptives ( birth control pills )
- Thiazides (for the treatment of high blood pressure or severe fluid retention)
- Glucocorticoids (eg cortisone for the treatment of inflammation )
- Thyroid hormones (for the treatment of thyroid diseases)
- Sympathomimetics (eg adrenaline or salbutamol , terbutaline for the treatment of asthma )
- Growth hormone (for stimulation of skeletal and body growth with a pronounced effect on the body’s metabolism)
- Danazol (an agent that affects ovulation).
Octreotide and lanreotide (for the treatment of acromegaly, an unusual hormonal disorder with pituitary overproduction one of the growth hormone usually in middle-aged adults) can either raise or lower your blood sugar level.
Beta-blockers (for the treatment of high blood pressure ) may weaken or eliminate the first warning signs of low blood sugar.
Pioglitazone (tablets for the treatment of type 2 diabetes )
Some patients who have had type 2 diabetes and heart disease for many years or previous strokes developed heart failure during treatment with pioglitazone and insulin. Tell your doctor as soon as possible if you get signs of heart failure such as unexpected shortness of breath, rapid weight gain, or local swelling ( edema ).
If you have taken any of these medicines, talk to your doctor, nurse, or pharmacist.
NovoRapid and drink alcohol
- If you drink alcohol, your need for insulin may change, as your blood sugar level may either rise or fall. Careful blood glucose monitoring is recommended.
Pregnancy and breastfeeding
- If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. NovoRapid can be used during pregnancy. The insulin dose may need to be changed during pregnancy and after delivery. Careful monitoring of your diabetes and counteracting low blood sugar is important for your baby’s health.
- There are no restrictions on treatment with NovoRapid during breast-feeding.
Ask your doctor, nurse, or pharmacist for advice before taking this medicine during pregnancy or breastfeeding.
Driving and using machines
Ask your doctor if you can drive or use machines:
- if you often get low blood sugar levels.
- if you find it difficult to recognize signs of low blood sugar (insulin detection).
If your blood sugar is low or high, then your ability to concentrate and react can be affected, and therefore also your ability to drive a vehicle or use machines. Remember that you can put yourself and others at risk.
The effect of NovoRapid is coming fast. This means that if you get low blood sugar, you can feel it faster than after injection of soluble human insulin.
Important information about some of the ingredients of NovoRapid
NovoRapid contains less than 1 mmol sodium (23 mg) per dose, ie NovoRapid is essential ‘sodium-free’.
How to use NovoRapid Penfill
Dose and when you take your insulin
Always use your insulin and make dose adjustments exactly as your doctor advised. If you are not sure, talk to your doctor, nurse, or pharmacist.
NovoRapid is usually taken immediately before a meal. Eat a meal or snack within 10 minutes of injecting one to avoid low blood sugar. If needed, NovoRapid can also be injected shortly after a meal. For information, see below How and where to inject.
Only change insulin preparations on the advice of a doctor. If your doctor has switched you from one type of insulin or brand of insulin to another, your dose may need to be adjusted by your doctor.
Use for children and adolescents
NovoRapid can be used in adolescents and children aged 1 year or older instead of soluble human insulin when it is good if the insulin acts quickly, for example when it is difficult to give the medicine to the child at the right time concerning meals.
Use for special patient groups
If you have impaired kidney or liver function or if you are over 65, you need to check your blood sugar more regularly and discuss changes in your insulin dose with your doctor.
How and where to inject
NovoRapid is for injection under the skin ( subcutaneously ). You should never inject yourself directly into a vein ( intravenously ) or muscle ( intramuscularly ). NovoRapid Penfill should only be injected under the skin with a reusable pen. Talk to your doctor if you need to inject your insulin using another method.
At each injection, change the injection site within the same specific skin area that you are using. This may reduce the risk of developing lumps or pits in the skin (see section 4, Possible side effects ). The best area to inject one is on: the front of the waist (abdomen), the upper arm, or the front of the thighs. Insulin acts faster if injected into the front of the waist. Always check your blood sugar regularly.
- Do not refill cartridge one . When empty, it must be discarded.
- NovoRapid Penfill cartridges are designed to be used with insulin injection devices from Novo Nordisk and NovoFine or NovoTwist injection needles.
- If you are taking both NovoRapid Penfill and another insulin Penfill cartridge , use two different injection aids, one for each type of insulin.
- Always carry an extra Penfill cartridge in case a cartridge is lost or damaged.
How NovoRapid is injected
- Inject insulin under the skin. Use the injection technique shown to you by your doctor or nurse and described in the instructions for use.
- Hold the injection needle under the skin for at least 6 seconds. Hold down the push-button completely until the needle has been withdrawn from the skin. This ensures that the correct dose has been injected and limits any blood flow into the needle or insulin container.
- Remove and discard the injection needle after each injection . Always keep NovoRapid without the needle attached. Liquid may otherwise leak and cause incorrect dosing .
If you take more insulin than you should
If you take too much insulin, your blood sugar may become too low (hypoglycemia). See a) Summary of serious and very common side effects in section 4.
If you forget to take your insulin
If you forget to take your insulin, your blood sugar may become too high (hyperglycemia). See c) Diabetes Disorders in Section 4.
If you stop taking your insulin
Do not stop insulin treatment without talking to a doctor, who will tell you what needs to be done. It can lead to very high blood sugar (severe hyperglycemia) and ketoacidosis. See c) Diabetes Disorders in Section 4.
If you have any further questions on the use of this product, ask your doctor, nurse, or pharmacist.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
a) Summary of serious and very common side effects
Low blood sugar ( hypoglycemia ) is a very common side effect. It can occur in more than 1 in 10 users.
Low blood sugar can occur if you:
- injecting too much insulin .
- eat too little or skip a meal.
- exercise more than usual.
- drink alcohol (see NovoRapid and drinking alcohol in section 2).
Signs of low blood sugar: Cold sweats; cool and pale skin; headache; palpitation; nausea; strong hunger; temporary vision changes; drowsiness; unusual fatigue and weakness; anxiety or trembling; feelings of anxiety; confusion; concentration difficulties.
Very low blood sugar can lead to unconsciousness. If left untreated for a very long time, very low blood sugar can cause brain damage (temporary or permanent) and even death. You can regain consciousness faster if you receive an injection of the hormone et glucagon from someone who knows how to use it. If you are given glucagon, you will need glucose or a sugar-containing snack as soon as you regain consciousness. If you do not respond to glucagon therapy, you will need to be treated in hospital.
What to do if you get low blood sugar:
- If you feel that your blood sugar is too low, eat grape sugar tablets or any other snack that contains a lot of sugar (sweets, cakes, fruit juice). If possible, check your blood sugar and rest. Always take glucose tablets or snacks with a lot of sugar in them for safety.
- When the symptoms of low blood sugar have disappeared or when your blood sugar level has stabilized, you should continue with the insulin treatment as usual.
- If you have had low blood sugar and lost consciousness or if you have needed a glucagon injection , or if you have had many insulin sensations, talk to a doctor. The amount of insulin or when you take it, diet or exercise may need to be adjusted.
Tell them that you have diabetes for people who need to know it, what the consequences can be, and also the risk of becoming unconscious due to low blood sugar. Tell them that if you become unconscious, they should put you on the side and get medical attention immediately. They must not give you anything to eat or drink as there is a risk that you will suffocate.
Severe allergic reactions to NovoRapid or any of the other ingredients (so-called systemic allergic reaction ) are very rare but can be life-threatening. It may affect less than 1 in 10,000 users.
Contact a doctor immediately:
- if signs of allergy spread to other parts of the body.
- if you suddenly feel unwell and you: start sweating; begins to vomit; have difficulty breathing; get palpitations; feel dizzy.
If you experience any of these, seek medical attention immediately.
Skin changes at the injection site: If you inject insulin at the same site, the adipose tissue may either shrink (lipoatrophy) or thicken (lipohypertrophy) (may affect up to 1 in 100 people). Nodules under the skin can also be caused by the accumulation of a protein called amyloid ( cutaneous amyloidosis. How often this occurs is not known). Insulin may not work as well if you inject in an area with lumps or in a thickened or shrunken area. Change the injection site for each injection to prevent these skin changes.
b) List of other side effects
Uncommon side effects are
May affect less than 1 in 100 users.
Signs of allergy: Local allergic reactions (pain, redness, hives, inflammation, bruising, swelling, and itching ) may occur at the injection site. These symptoms usually go away after taking your insulin for a few weeks. If they do not disappear or spread throughout the body, talk to a doctor immediately. See also Severe allergic reactions above.
Vision problems: At the beginning of insulin treatment, visual disturbances may occur, but these are usually temporary.
Swollen joints: When you start taking insulin, your body may bind water, causing you to swell around the ankles and other joints. This usually goes away soon, otherwise, you should talk to a doctor.
Diabetic retinopathy (an eye disease associated with diabetes and can lead to loss of vision): If you have diabetic retinopathy, it can worsen if your blood sugar level improves very quickly. Ask your doctor about this.
Rare side effects
May affect less than 1 in 1,000 users.
Painful neuropathy (pain due to nerve damage): If your blood sugar level improves very quickly, you may get nerve-related pain. This is called acute painful neuropathy and is usually transient.
c) Problems with diabetes
High blood sugar (hyperglycemia)
High blood sugar can occur if you:
- have not injected enough insulin .
- forget to take your insulin or stop taking insulin .
- repeatedly take less insulin than you need.
- gets an infection and / or fever.
- eat more than usual.
- exercise less than usual.
High blood sugar warning signs:
The warning signals appear gradually. They manifest as: increased urine output; thirst; loss of appetite; feeling sick (nausea or vomiting); drowsiness or fatigue; redness; dry skin; dry mouth and a breath that smells of fruit (acetone).
What should I do if I get high blood sugar:
- If you get any of the above warning signs: check your blood sugar, do a ketone test on your urine if possible and then contact a doctor immediately.
- The symptoms can be a sign of a very serious condition called diabetic ketoacidosis (accumulation of acid in the blood when the body breaks down fat instead of sugar). If left untreated, it can lead to diabetic coma and eventually death.
How to store NovoRapid Penfill
Keep this medicine out of the sight and reach of children.
Do not use this medicine before the expiry date which is stated on the label and carton of the cartridges after “EXP”. The expiration date is the last day of the specified month.
Always keep the cartridge in the outer carton when not in use. Sensitive to light. NovoRapid must be protected from strong heat and light.
Unopened packaging: Unused NovoRapid Penfill should be stored in a refrigerator from 2 ° C to 8 ° C, not near the cooling element. Do not freeze.
During use or with as a spare: NovoRapid Penfill that is currently being used or taken as a spare should not be stored in the refrigerator. You can take it with you and store it at room temperature (maximum 30 ° C) for up to 4 weeks.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Contents of the package and other information
Content declaration
- The active substance is insulin aspart. Each ml contains 100 units of insulin aspart. Each cartridge contains 300 units of insulin aspart in 3 ml solution for injection .
- The other ingredients are glycerol , phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid , sodium hydroxide and water for injections.
What the medicine looks like and contents of the pack
NovoRapid is in the form of a solution for injection.
Pack sizes: 5 and 10 cartridges of 3 ml. Not all pack sizes may be marketed.
The solution is clear and colorless.
Marketing Authorization Holder and Manufacturer
Marketing Authorisation Holder
Novo Nordisk A / S, Novo Allé, DK-2880 Bagsværd, Denmark
Manufacturer
The manufacturer can be identified by the batch number printed on the tab on the carton and the label:
- If the second and third characters are S6, P5, K7, R7, VG, FG or ZF, the manufacturer is Novo Nordisk A / S, Novo Allé, DK-2880 Bagsværd, Denmark
- If the second and third characters are H7 or T6, the manufacturer is Novo Nordisk Production SAS, 45 Avenue d’Orléans, F-28000 Chartres, France.